 Anthony Saviola
Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Crotalid Venoms | 14 | 2025 | 31 | 4.650 |
Why?
| | Crotalus | 14 | 2025 | 26 | 3.960 |
Why?
| | Snake Venoms | 11 | 2024 | 21 | 2.320 |
Why?
| | Proteomics | 17 | 2025 | 1062 | 2.090 |
Why?
| | Proteome | 7 | 2025 | 443 | 1.110 |
Why?
| | Disintegrins | 2 | 2016 | 5 | 1.010 |
Why?
| | Colubridae | 3 | 2021 | 8 | 0.870 |
Why?
| | Antivenins | 4 | 2025 | 35 | 0.780 |
Why?
| | Head and Neck Neoplasms | 5 | 2024 | 544 | 0.770 |
Why?
| | Neglected Diseases | 1 | 2020 | 4 | 0.680 |
Why?
| | Animals | 43 | 2025 | 35361 | 0.610 |
Why?
| | Metalloproteases | 4 | 2024 | 44 | 0.570 |
Why?
| | Cell Adhesion | 2 | 2016 | 452 | 0.570 |
Why?
| | L-Amino Acid Oxidase | 4 | 2019 | 4 | 0.560 |
Why?
| | Mass Spectrometry | 5 | 2023 | 716 | 0.530 |
Why?
| | Predatory Behavior | 2 | 2016 | 44 | 0.530 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 59 | 0.470 |
Why?
| | Elapid Venoms | 2 | 2025 | 17 | 0.470 |
Why?
| | Biological Evolution | 2 | 2017 | 427 | 0.430 |
Why?
| | Extracellular Matrix | 6 | 2025 | 504 | 0.370 |
Why?
| | Mice | 17 | 2025 | 16937 | 0.340 |
Why?
| | Phospholipases A2 | 5 | 2025 | 79 | 0.330 |
Why?
| | Melanoma | 1 | 2016 | 730 | 0.310 |
Why?
| | Tumor Microenvironment | 4 | 2025 | 634 | 0.300 |
Why?
| | Transcriptome | 2 | 2025 | 887 | 0.270 |
Why?
| | Viper Venoms | 2 | 2018 | 9 | 0.270 |
Why?
| | Fibrosis | 3 | 2024 | 520 | 0.270 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 3 | 2019 | 330 | 0.270 |
Why?
| | Toxins, Biological | 2 | 2023 | 11 | 0.250 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4063 | 0.250 |
Why?
| | Extracellular Matrix Proteins | 2 | 2024 | 144 | 0.240 |
Why?
| | Coral Snakes | 1 | 2025 | 3 | 0.240 |
Why?
| | Mexico | 3 | 2025 | 190 | 0.240 |
Why?
| | Protein Phosphatase 1 | 1 | 2025 | 34 | 0.240 |
Why?
| | Interleukin-2 | 2 | 2023 | 436 | 0.240 |
Why?
| | Biomimetics | 1 | 2025 | 43 | 0.240 |
Why?
| | Transcription Termination, Genetic | 1 | 2025 | 19 | 0.230 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.230 |
Why?
| | Mammary Glands, Human | 1 | 2025 | 64 | 0.230 |
Why?
| | Dystrophin | 1 | 2024 | 34 | 0.230 |
Why?
| | Prodrugs | 1 | 2025 | 48 | 0.230 |
Why?
| | Receptor, EphB4 | 1 | 2024 | 36 | 0.230 |
Why?
| | Ephrin-B2 | 1 | 2024 | 50 | 0.230 |
Why?
| | Ribonucleoprotein, U1 Small Nuclear | 1 | 2024 | 13 | 0.230 |
Why?
| | Indoles | 2 | 2025 | 387 | 0.230 |
Why?
| | Biomimetic Materials | 1 | 2025 | 70 | 0.230 |
Why?
| | Keto Acids | 1 | 2024 | 13 | 0.230 |
Why?
| | Printing, Three-Dimensional | 1 | 2025 | 87 | 0.230 |
Why?
| | PPAR alpha | 1 | 2024 | 58 | 0.220 |
Why?
| | Oleic Acid | 1 | 2024 | 39 | 0.220 |
Why?
| | Snake Bites | 1 | 2024 | 28 | 0.220 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2024 | 40 | 0.220 |
Why?
| | Lactation | 1 | 2025 | 170 | 0.220 |
Why?
| | Interleukin-7 | 1 | 2024 | 59 | 0.220 |
Why?
| | Hydroxamic Acids | 1 | 2024 | 88 | 0.220 |
Why?
| | Herpesvirus 3, Human | 2 | 2024 | 331 | 0.220 |
Why?
| | Acetates | 1 | 2024 | 100 | 0.210 |
Why?
| | Milk, Human | 1 | 2025 | 151 | 0.210 |
Why?
| | Lipid Droplets | 1 | 2023 | 21 | 0.210 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2025 | 270 | 0.210 |
Why?
| | Birth Injuries | 1 | 2023 | 10 | 0.210 |
Why?
| | Lethal Dose 50 | 2 | 2025 | 15 | 0.210 |
Why?
| | Phenotype | 6 | 2023 | 3076 | 0.210 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3215 | 0.210 |
Why?
| | Necrosis | 1 | 2024 | 232 | 0.210 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 159 | 0.210 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2344 | 0.210 |
Why?
| | RNA Precursors | 1 | 2024 | 147 | 0.210 |
Why?
| | Protein Isoforms | 1 | 2024 | 391 | 0.200 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 45 | 0.200 |
Why?
| | Collagen Type I | 1 | 2023 | 119 | 0.200 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 201 | 0.200 |
Why?
| | RNA Splicing | 1 | 2024 | 262 | 0.200 |
Why?
| | Vascular Remodeling | 1 | 2024 | 192 | 0.200 |
Why?
| | Peptide Hydrolases | 1 | 2023 | 107 | 0.200 |
Why?
| | Herpes Zoster | 2 | 2024 | 317 | 0.200 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 130 | 0.200 |
Why?
| | Gene Expression | 2 | 2025 | 1472 | 0.190 |
Why?
| | Ventricular Remodeling | 1 | 2024 | 255 | 0.190 |
Why?
| | RNA Polymerase II | 1 | 2025 | 317 | 0.190 |
Why?
| | Humans | 30 | 2025 | 129650 | 0.190 |
Why?
| | Progesterone | 1 | 2023 | 245 | 0.190 |
Why?
| | Myocardium | 2 | 2024 | 980 | 0.190 |
Why?
| | RNA-Binding Proteins | 1 | 2025 | 388 | 0.190 |
Why?
| | Peptides | 3 | 2023 | 925 | 0.190 |
Why?
| | Microglia | 1 | 2024 | 235 | 0.190 |
Why?
| | MCF-7 Cells | 3 | 2018 | 116 | 0.190 |
Why?
| | Thrombosis | 2 | 2023 | 343 | 0.180 |
Why?
| | Virulence Factors | 1 | 2022 | 156 | 0.180 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 596 | 0.170 |
Why?
| | Evolution, Molecular | 1 | 2024 | 466 | 0.170 |
Why?
| | Nuclear Proteins | 1 | 2025 | 663 | 0.170 |
Why?
| | Semen | 1 | 2020 | 19 | 0.170 |
Why?
| | Saccharomyces cerevisiae | 1 | 2024 | 532 | 0.170 |
Why?
| | Drug Discovery | 1 | 2021 | 131 | 0.160 |
Why?
| | Cardiomyopathies | 1 | 2023 | 340 | 0.160 |
Why?
| | Trimeresurus | 1 | 2019 | 1 | 0.160 |
Why?
| | Chromatin | 1 | 2023 | 479 | 0.160 |
Why?
| | Mice, Knockout | 2 | 2024 | 2871 | 0.160 |
Why?
| | Serine Proteases | 1 | 2019 | 20 | 0.160 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 46 | 0.160 |
Why?
| | Fibrinolytic Agents | 1 | 2021 | 263 | 0.160 |
Why?
| | Pancreatic Neoplasms | 2 | 2025 | 882 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2025 | 1065 | 0.150 |
Why?
| | Gene Expression Regulation | 2 | 2025 | 2548 | 0.150 |
Why?
| | Reptilian Proteins | 1 | 2018 | 3 | 0.150 |
Why?
| | Hydrogels | 2 | 2023 | 638 | 0.150 |
Why?
| | Proteins | 2 | 2023 | 942 | 0.150 |
Why?
| | Metabolomics | 1 | 2023 | 652 | 0.150 |
Why?
| | Mitochondria | 1 | 2024 | 877 | 0.150 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 137 | 0.150 |
Why?
| | Alzheimer Disease | 1 | 2024 | 519 | 0.140 |
Why?
| | Gryllidae | 1 | 2017 | 1 | 0.140 |
Why?
| | Apoptosis | 2 | 2018 | 2503 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2024 | 857 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1443 | 0.140 |
Why?
| | Southwestern United States | 1 | 2017 | 91 | 0.140 |
Why?
| | Lizards | 1 | 2017 | 34 | 0.140 |
Why?
| | Hypoxia | 1 | 2024 | 1084 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1022 | 0.130 |
Why?
| | RNA | 1 | 2023 | 883 | 0.130 |
Why?
| | Adenylyl Cyclases | 1 | 2016 | 83 | 0.130 |
Why?
| | Integrin alphaVbeta3 | 1 | 2016 | 19 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2018 | 423 | 0.130 |
Why?
| | Cattle | 3 | 2024 | 976 | 0.130 |
Why?
| | Bacteria | 1 | 2022 | 821 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1706 | 0.120 |
Why?
| | Vitronectin | 1 | 2015 | 5 | 0.120 |
Why?
| | Neutralization Tests | 2 | 2025 | 73 | 0.120 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 524 | 0.120 |
Why?
| | DNA, Complementary | 1 | 2015 | 270 | 0.120 |
Why?
| | Fibronectins | 1 | 2015 | 123 | 0.120 |
Why?
| | Stroke | 1 | 2023 | 1071 | 0.110 |
Why?
| | Phylogeny | 3 | 2025 | 852 | 0.110 |
Why?
| | Geography | 1 | 2015 | 188 | 0.110 |
Why?
| | Neoplasms | 2 | 2021 | 2470 | 0.110 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 328 | 0.110 |
Why?
| | Tumor Suppressor Proteins | 1 | 2016 | 317 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2025 | 2061 | 0.110 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2023 | 82 | 0.100 |
Why?
| | Chromatography, Gel | 1 | 2013 | 127 | 0.100 |
Why?
| | Hypertension, Pulmonary | 1 | 2024 | 1894 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2015 | 582 | 0.100 |
Why?
| | Molecular Weight | 1 | 2013 | 332 | 0.100 |
Why?
| | Zinc | 1 | 2015 | 294 | 0.090 |
Why?
| | Female | 9 | 2025 | 68776 | 0.090 |
Why?
| | Cell Movement | 1 | 2016 | 945 | 0.090 |
Why?
| | Mammals | 2 | 2023 | 271 | 0.090 |
Why?
| | Immunotherapy | 2 | 2025 | 592 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 474 | 0.080 |
Why?
| | Heart Failure | 1 | 2022 | 2150 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2058 | 0.080 |
Why?
| | Protein Binding | 2 | 2025 | 2121 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2016 | 2391 | 0.070 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2832 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2025 | 835 | 0.070 |
Why?
| | Male | 5 | 2024 | 63681 | 0.070 |
Why?
| | Exocrine Glands | 1 | 2025 | 5 | 0.060 |
Why?
| | Salivary Glands | 1 | 2025 | 29 | 0.060 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.060 |
Why?
| | Drug Liberation | 1 | 2025 | 30 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4421 | 0.060 |
Why?
| | Naja | 1 | 2024 | 1 | 0.060 |
Why?
| | RNA Splice Sites | 1 | 2024 | 44 | 0.060 |
Why?
| | Elapidae | 1 | 2024 | 5 | 0.060 |
Why?
| | Acute-Phase Proteins | 1 | 2024 | 67 | 0.060 |
Why?
| | Serpins | 1 | 2024 | 31 | 0.060 |
Why?
| | Varicella Zoster Virus Infection | 1 | 2024 | 25 | 0.060 |
Why?
| | Drug Repositioning | 1 | 2024 | 25 | 0.060 |
Why?
| | Fenofibrate | 1 | 2024 | 31 | 0.060 |
Why?
| | Saccharomycetales | 1 | 2024 | 26 | 0.060 |
Why?
| | Virus Activation | 1 | 2024 | 88 | 0.050 |
Why?
| | Acrylamides | 1 | 2024 | 58 | 0.050 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 89 | 0.050 |
Why?
| | Corpus Luteum | 1 | 2023 | 20 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 110 | 0.050 |
Why?
| | Species Specificity | 1 | 2025 | 575 | 0.050 |
Why?
| | Trypsin | 1 | 2023 | 74 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 23 | 0.050 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 103 | 0.050 |
Why?
| | Snakes | 1 | 2023 | 20 | 0.050 |
Why?
| | HeLa Cells | 1 | 2025 | 608 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 25 | 0.050 |
Why?
| | Nucleocapsid | 1 | 2023 | 18 | 0.050 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2023 | 20 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2015 | 2142 | 0.050 |
Why?
| | Protein Domains | 1 | 2024 | 253 | 0.050 |
Why?
| | Aminophenols | 1 | 2025 | 144 | 0.050 |
Why?
| | Chromosomes | 1 | 2023 | 101 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 69 | 0.050 |
Why?
| | Cyclophilins | 1 | 2023 | 41 | 0.050 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2023 | 169 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2024 | 202 | 0.050 |
Why?
| | Hormones | 1 | 2023 | 140 | 0.050 |
Why?
| | Keratinocytes | 1 | 2024 | 242 | 0.050 |
Why?
| | Steroids | 1 | 2023 | 158 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 216 | 0.050 |
Why?
| | Serine | 1 | 2023 | 138 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2025 | 697 | 0.050 |
Why?
| | Proteoglycans | 1 | 2023 | 110 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 155 | 0.050 |
Why?
| | Cardiomegaly | 1 | 2023 | 172 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2024 | 610 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 70 | 0.050 |
Why?
| | Exosomes | 1 | 2023 | 96 | 0.050 |
Why?
| | Gene Regulatory Networks | 1 | 2024 | 284 | 0.050 |
Why?
| | Viral Proteins | 1 | 2024 | 328 | 0.050 |
Why?
| | Sympatry | 1 | 2021 | 13 | 0.050 |
Why?
| | Complement System Proteins | 1 | 2024 | 313 | 0.050 |
Why?
| | Arginine | 1 | 2023 | 265 | 0.050 |
Why?
| | Plasma | 1 | 2023 | 206 | 0.050 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 232 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 347 | 0.040 |
Why?
| | Fatty Acids | 1 | 2024 | 427 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2024 | 527 | 0.040 |
Why?
| | Pregnancy | 2 | 2023 | 6402 | 0.040 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2024 | 385 | 0.040 |
Why?
| | India | 1 | 2021 | 170 | 0.040 |
Why?
| | Phosphorylation | 1 | 2025 | 1713 | 0.040 |
Why?
| | Metabolome | 1 | 2023 | 338 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5440 | 0.040 |
Why?
| | Signal Transduction | 2 | 2024 | 4925 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 434 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 499 | 0.040 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2020 | 27 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2021 | 238 | 0.040 |
Why?
| | Swine | 1 | 2022 | 760 | 0.040 |
Why?
| | Electron Transport | 1 | 2020 | 112 | 0.040 |
Why?
| | Islands | 1 | 2019 | 3 | 0.040 |
Why?
| | Indonesia | 1 | 2019 | 21 | 0.040 |
Why?
| | Skin | 1 | 2024 | 725 | 0.040 |
Why?
| | Lectins, C-Type | 1 | 2019 | 71 | 0.040 |
Why?
| | Gelatin | 1 | 2019 | 42 | 0.040 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1418 | 0.040 |
Why?
| | Conserved Sequence | 1 | 2019 | 227 | 0.040 |
Why?
| | Pulmonary Artery | 1 | 2024 | 1096 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 166 | 0.040 |
Why?
| | Biocompatible Materials | 1 | 2022 | 395 | 0.040 |
Why?
| | Caspase 8 | 1 | 2018 | 48 | 0.040 |
Why?
| | Caspase 9 | 1 | 2018 | 56 | 0.040 |
Why?
| | Fibrinogen | 1 | 2019 | 164 | 0.040 |
Why?
| | Guam | 1 | 2017 | 7 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2025 | 1269 | 0.040 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2018 | 68 | 0.040 |
Why?
| | Stem Cells | 1 | 2022 | 577 | 0.040 |
Why?
| | Introduced Species | 1 | 2017 | 36 | 0.040 |
Why?
| | MicroRNAs | 1 | 2024 | 678 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2024 | 1056 | 0.040 |
Why?
| | Ultraviolet Rays | 1 | 2020 | 383 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2023 | 1119 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2022 | 781 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 637 | 0.030 |
Why?
| | Glutathione | 1 | 2018 | 348 | 0.030 |
Why?
| | Caspase 7 | 1 | 2015 | 22 | 0.030 |
Why?
| | Pakistan | 1 | 2015 | 75 | 0.030 |
Why?
| | Rats | 1 | 2023 | 5500 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 811 | 0.030 |
Why?
| | Risk Assessment | 1 | 2023 | 3240 | 0.030 |
Why?
| | Inflammation | 1 | 2024 | 2736 | 0.030 |
Why?
| | Aging | 1 | 2024 | 1776 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1614 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1488 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2020 | 3083 | 0.020 |
Why?
| | Brain | 1 | 2024 | 2679 | 0.020 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 752 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3144 | 0.020 |
Why?
| | Aged | 1 | 2024 | 22103 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 31154 | 0.010 |
Why?
|
|
Saviola's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|